David Mazzo

Directeur Général chez LISATA THERAPEUTICS, INC. Fortune : 636 276 $ au 30/06/2026

Profil

David J.
Mazzo currently works at Lisata Therapeutics, Inc., as President, Chief Executive Officer & Director from 2017, Feldan Bio, Inc., as Chairman from 2023, American Association of Pharmaceutical Scientists, as Member, AOAC International, as Member, and Bonnie Brae, Inc., as Trustee from 2010.
Dr. Mazzo also formerly worked at Æterna Zentaris, Inc., as President, CEO & Executive Director from 2007 to 2008, Regado Biosciences, Inc., as Chief Executive Officer & Executive Director from 2013 to 2014, Caladrius Biosciences, Inc., as Chief Executive Officer & Director from 2015 to 2017, Chugai Pharma USA LLC, as President, CEO & Executive Director from 2003 to 2007, Essex Chimie AG, as Chief Executive Officer & Director, Visioneering Technologies, Inc., as Chairman from 2020 to 2024, Schering-Plough Corp., as Director, Avanir Pharmaceuticals, Inc., as Independent Director from 2011 to 2015, Rhone-Poulenc Rorer, Inc., as Senior Director from 1991 to 1997, EyePoint Pharmaceuticals, Inc., as Independent Non-Executive Director from 2018 to 2020, Seneca Biopharma, Inc., as Independent Director from 2019 to 2021, Hoechst Marion Roussel, Inc., as Director, Essex SAS, as Director, Hoechst Marion Roussel Ltd. (United Kingdom), as SVP-Global Head Pharmaceutical Development, Roche Group, as Member, and Schering-Plough Research Institute, as Senior Vice President-Development Operations from 1998 to 2002.
Dr. Mazzo received his graduate degree and doctorate degree from the University of Massachusetts and undergraduate degree in 1979 from Villanova University.

Détentions connues dans des sociétés publiques

Société	Date	Nombre d'actions	Valorisation	Date de valorisation
LISATA THERAPEUTICS, INC. 2,06 %	09/01/2026	187 140 ( 2,06 % )	636 276 $	30/06/2026

Postes actifs de David Mazzo

Sociétés	Poste	Début
LISATA THERAPEUTICS, INC.	Directeur Général	05/01/2015
Feldan Bio, Inc.	Président	01/10/2023
Bonnie Brae, Inc.	Directeur/Membre du Conseil	30/12/2010
AOAC International	Corporate Officer/Principal	-
American Association of Pharmaceutical Scientists	Corporate Officer/Principal	-

Anciens postes connus de David Mazzo

Sociétés	Poste	Fin
VISG TECHUNSP GDR	Président	29/02/2024
PALISADE BIO, INC.	Directeur/Membre du Conseil	27/04/2021
EYEPOINT, INC.	Président	10/09/2018
AVANIR PHARMACEUTICALS INC	Directeur/Membre du Conseil	13/01/2015
░░░░░░ ░░░░░░░░░░░░ ░░░░	░░░░░░░░░ ░░░░░░░░░	░░░░░░░░░░